Retiring congressman to head pharmaceutical trade group
26206
Retiring US Rep. Billy Tauzin, who left his post as head of the House committee that regulates the pharmaceutical industry earlier this year, will become head of the industry&#39;s top lobbying group next month.
98099
The Florida representative and former House Intelligence Committee chairman will take over from George Tenet. Mr Goss was a spy for more than 10 years before entering Congress.
244685
Sept. 30, 2004âReacting to calls from pharmaceutical retailers, distributors and manufacturers, EPCglobal has added a new action group to specifically study the pharmaceutical industry
22491
Raymond Gilmartin, chief executive of Merck, will testify before a Senate committee this week on the withdrawal of Vioxx, in spite of efforts by the drug company to send others in his place.
495237
The Pharmaceutical Research and Manufacturers of America announced yesterday that retiring Rep. WJ&quot;Billy&quot; Tauzin (R-La.), chairman of the powerful House Committee on Energy and Commerce until
607555
Proposed legislation could spell changes across the pharmaceutical world.
613309
The former chairman of the U.S.  House of Representatives Energy and Commerce Committee, who  earlier this year ended negotiations to head the pharmaceutical  industry's top lobby after critics questioned the ethics of the  move, has now accepted the post, the group said on Wednesday.
732904
As Deborah P. Majoras takes over the Federal Trade Commission on Monday, she's expected to build on the broad agenda set by her predecessor, Timothy J. Muris.
300953
Retiring US Rep. Billy Tauzin, former House Commerce Committee chairman and a principal architect of the prescription drug benefit for Medicare, will become the new president and CEO of
459725
A top Republican lawmaker raised concerns about the U.S. Food and Drug Administration's ability to monitor drug safety following Merck & Co. Inc.'s recall of its arthritis drug last week, according to a letter made public on Tuesday.
707318
Lester Crawford, the acting head of the US Food and Drug Administration on Friday agreed to meet with Republican Sen. Charles Grassley to discuss the FDA&#39;s handling of safety concerns over Merck&#39;s arthritis drug Vioxx.
692785
Representative Billy Tauzin, a principal author of the new Medicare drug law, will become president of the Pharmaceutical Research and Manufacturers of America, the chief
712560
By Erica Werner  WASHINGTON - Rep. Nick Rahall, the incoming Democratic chairman of the House committee that writes environmental laws, on Friday promised a new focus for the committee - starting with a new name.
593726
The pharmaceutical industry, fighting to defeat proposals that would give U.S. patients easier access to cheaper Canadian drugs, is making the most of its chance for face time with lawmakers at the GOP convention...
77107
Bloomberg - Dec. 8 (Bloomberg) -- House lawmakers are working to pass legislation to extend dozens of trade and tax benefits and preserve fees that Medicare pays doctors knowing that some senators may object when it gets to their chamber.
423544
Retiring Rep. Billy Tauzin, who led the House committee that regulates drug makers, will become head of the industry's top lobbying group next month.
743520
A top Republican lawmaker raised  concerns about the U.S. Food and Drug Administration's ability  to monitor drug safety following Merck & Co. Inc.'s recall of  its arthritis drug last week, according to a letter made public  on Tuesday.